Literature DB >> 7483139

Establishment and characterization of a new cell line from human bladder cancer (JMSU1).

T Morita1, N Shinohara, M Honma, A Tokue.   

Abstract

A new human bladder cancer cell line designated JMSU1 has been established from malignant ascitic fluid of a 75-year-old Japanese man with bladder cancer, and maintained in culture for more than 7 years and over 240 passages. Inverted phase-contrast microscopy revealed that JMSU1 was composed of morphologically distinct cells (polygonal to spindle-shaped cells), showing morphological heterogeneity in vitro. Histological examination of xenografts showed poorly differentiated transitional cell carcinoma, resembling the original tumor. Immunohistochemical staining for cytokeratin and electron microscopic examination suggested that JMSU1 was of epithelial origin. Chromosome analysis gave a modal number of 69 with no Y chromosome. Isozyme analysis (LDH, G6PD, and NP) showed the mobility pattern of human type B. DNA fingerprint analysis demonstrated that there was no cross-culture contamination of JMSU1 during the passages. In conclusion, a newly established and well-characterized cell line, JMSU1, offers promising material for the investigation of the biological properties of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483139     DOI: 10.1007/bf00389565

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  18 in total

Review 1.  Human urologic cancer cell lines.

Authors:  R D Williams
Journal:  Invest Urol       Date:  1980-03

2.  Fingerprinting cell lines: use of human hypervariable DNA probes to characterize mammalian cell cultures.

Authors:  J Thacker; M B Webb; P G Debenham
Journal:  Somat Cell Mol Genet       Date:  1988-11

3.  Individual-specific 'fingerprints' of human DNA.

Authors:  A J Jeffreys; V Wilson; S L Thein
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

4.  Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

Authors:  J Bubeník; M Baresová; V Viklický; J Jakoubková; H Sainerová; J Donner
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

Review 5.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

Review 6.  Cross-contamination of cells in culture.

Authors:  W A Nelson-Rees; D W Daniels; R R Flandermeyer
Journal:  Science       Date:  1981-04-24       Impact factor: 47.728

7.  Cell culture characterization: monitoring for cell identification.

Authors:  W D Peterson; W F Simpson; B Hukku
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

8.  Morphological characterization of two established cell lines, T24 and MGH-U1, derived from human urinary bladder carcinoma.

Authors:  T Kato; K Ishikawa; R Nemoto; A Senoo; Y Amano
Journal:  Tohoku J Exp Med       Date:  1978-04       Impact factor: 1.848

9.  Establishment and characterization of four human bladder tumor cell lines and sublines with different degrees of malignancy.

Authors:  C W Lin; J C Lin; G R Prout
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

10.  Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity.

Authors:  J L Brown; P J Russell; J Philips; J Wotherspoon; D Raghavan
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

View more
  3 in total

Review 1.  Cell cross-contamination in cell cultures: the silent and neglected danger.

Authors:  O Markovic; N Markovic
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

2.  Human pancreatic leiomyosarcoma (PZX-7) growing as a serially transplantable xenograft in immunosuppressed mice.

Authors:  A Zalatnai; J Bocsi; T Csákány; T Fekete; J Lásztity
Journal:  Int J Pancreatol       Date:  1999-08

3.  Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents.

Authors:  Kazumasa Komura; Teruo Inamoto; Takuya Tsujino; Yusuke Matsui; Tsuyoshi Konuma; Kazuki Nishimura; Taizo Uchimoto; Takeshi Tsutsumi; Tomohisa Matsunaga; Ryoichi Maenosono; Yuki Yoshikawa; Kohei Taniguchi; Tomohito Tanaka; Hirofumi Uehara; Koichi Hirata; Hajime Hirano; Hayahito Nomi; Yoshinobu Hirose; Fumihito Ono; Haruhito Azuma
Journal:  Oncogene       Date:  2021-09-20       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.